Literature DB >> 33665210

Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19.

Yonghao Lan1,2, Wei Liu2,3, Yujie Zhou2,3.   

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, is a global pandemic. It has resulted in considerable morbidity and mortality around the world. The respiratory system is the main system invaded by the virus involved in COVID-19. In addition to typical respiratory manifestations, a certain proportion of severe COVID-19 cases present with evidence of myocardial injury, which is associated with excessive mortality. With availability of an increasing amount of imaging data, right ventricular (RV) damage is prevalent in patients with COVID-19 and myocardial injury, while left ventricular damage is relatively rare and lacks specificity. The mechanisms of RV damage may be due to increased RV afterload and decreased RV contractility caused by various factors, such as acute respiratory distress syndrome, pulmonary thrombosis, direct viral injury, hypoxia, inflammatory response and autoimmune injury. RV dysfunction usually indicates a poor clinical outcome in patients with COVID-19. Timely and effective treatment is of vital importance to save patients' lives as well as improve prognosis. By use of echocardiography or cardiovascular magnetic resonance, doctors can find RV dilatation and dysfunction early. By illustrating the phenomenon of RV damage and its potential pathophysiological mechanisms, we will guide doctors to give timely medical treatments (e.g., anticoagulants, diuretics, cardiotonic), and device-assisted therapy (e.g., mechanical ventilation, extracorporeal membrane oxygenation) when necessary for these patients. In the paper, we examined the latest relevant studies to investigate the imaging features, potential mechanisms, and treatments of myocardial damage caused by COVID-19. RV damage may be an association between myocardial damage and lung injury in COVID-19. Early assessment of RV geometry and function will be helpful in aetiological determination and adjustment of treatment options.
Copyright © 2021 Lan, Liu and Zhou.

Entities:  

Keywords:  ARDS; COVID-19; cardiovascular magnetic resonance; echocardiography; myocardial injury; right ventricular damage

Year:  2021        PMID: 33665210      PMCID: PMC7920943          DOI: 10.3389/fcvm.2021.606318

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  66 in total

Review 1.  Pulmonary embolism.

Authors:  Menno V Huisman; Stefano Barco; Suzanne C Cannegieter; Gregoire Le Gal; Stavros V Konstantinides; Pieter H Reitsma; Marc Rodger; Anton Vonk Noordegraaf; Frederikus A Klok
Journal:  Nat Rev Dis Primers       Date:  2018-05-17       Impact factor: 52.329

Review 2.  At the heart of COVID-19.

Authors:  Inayat Hussain Khan; Syeda Anum Zahra; Sevim Zaim; Amer Harky
Journal:  J Card Surg       Date:  2020-05-05       Impact factor: 1.620

3.  Clinical Features of Acute and Fulminant Myocarditis in Children - 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery.

Authors:  Hiroyuki Matsuura; Fukiko Ichida; Tsutomu Saji; Shunichi Ogawa; Kenji Waki; Masahide Kaneko; Masahiro Tahara; Takashi Soga; Yasuo Ono; Satoshi Yasukochi
Journal:  Circ J       Date:  2016-10-04       Impact factor: 2.993

4.  Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome.

Authors:  Florence Boissier; Sandrine Katsahian; Keyvan Razazi; Arnaud W Thille; Ferran Roche-Campo; Rusel Leon; Emmanuel Vivier; Laurent Brochard; Antoine Vieillard-Baron; Christian Brun-Buisson; Armand Mekontso Dessap
Journal:  Intensive Care Med       Date:  2013-05-15       Impact factor: 17.440

5.  Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.

Authors:  Matthias G Friedrich; Udo Sechtem; Jeanette Schulz-Menger; Godtfred Holmvang; Pauline Alakija; Leslie T Cooper; James A White; Hassan Abdel-Aty; Matthias Gutberlet; Sanjay Prasad; Anthony Aletras; Jean-Pierre Laissy; Ian Paterson; Neil G Filipchuk; Andreas Kumar; Matthias Pauschinger; Peter Liu
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

6.  [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].

Authors:  C Chen; C Chen; J T Yan; N Zhou; J P Zhao; D W Wang
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2020-07-24

7.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

Authors:  Shaobo Shi; Mu Qin; Bo Shen; Yuli Cai; Tao Liu; Fan Yang; Wei Gong; Xu Liu; Jinjun Liang; Qinyan Zhao; He Huang; Bo Yang; Congxin Huang
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

8.  Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality.

Authors:  Robert O Bonow; Gregg C Fonarow; Patrick T O'Gara; Clyde W Yancy
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

9.  Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.

Authors:  Qing Deng; Bo Hu; Yao Zhang; Hao Wang; Xiaoyang Zhou; Wei Hu; Yuting Cheng; Jie Yan; Haiqin Ping; Qing Zhou
Journal:  Int J Cardiol       Date:  2020-04-08       Impact factor: 4.164

Review 10.  Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective.

Authors:  Marouane Boukhris; Ali Hillani; Francesco Moroni; Mohamed Salah Annabi; Faouzi Addad; Marcelo Harada Ribeiro; Samer Mansour; Xiaohui Zhao; Luiz Fernando Ybarra; Antonio Abbate; Luz Maria Vilca; Lorenzo Azzalini
Journal:  Can J Cardiol       Date:  2020-05-16       Impact factor: 6.614

View more
  6 in total

1.  Continuous long-term wireless measurement of right ventricular pressures and estimated diastolic pulmonary artery pressure in patients with severe COVID-19 acute respiratory distress syndrome.

Authors:  Matthias Gaertner; Raymond Glocker; Felix Glocker; Hans-Bernd Hopf
Journal:  ESC Heart Fail       Date:  2021-09-06

2.  Right ventricle early inflow-outflow index may inform about the severity of pneumonia in patients with COVID-19.

Authors:  Muzaffer Kahyaoglu; MuratCan Guney; Derya Deniz; Ertugrul Kilic
Journal:  J Clin Ultrasound       Date:  2021-10-28       Impact factor: 0.869

3.  Assessment of Right Ventricular Mechanics by 3D Transesophageal Echocardiography in the Early Phase of Acute Respiratory Distress Syndrome.

Authors:  Bruno Evrard; Bálint Károly Lakatos; Marine Goudelin; Zoltán Tősér; Béla Merkely; Philippe Vignon; Attila Kovács
Journal:  Front Cardiovasc Med       Date:  2022-05-03

Review 4.  The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment.

Authors:  Langjiao Liu; Haijiao Jing; Xiaoming Wu; Mengqi Xiang; Valerie A Novakovic; Shuye Wang; Jialan Shi
Journal:  Front Cardiovasc Med       Date:  2022-08-05

5.  Letter to the Editor: Influence of right ventricular structure and function on hospital outcomes in COVID-19 patients.

Authors:  Dr Mustafa Javaid; Dr Faizan Masood; Dr Arsalan Nadeem
Journal:  Heart Lung       Date:  2022-09-07       Impact factor: 3.149

6.  Long term effects of mild severity COVID‑19 on right ventricular functions.

Authors:  Fatih Akkaya; Feyza Nur Topçu Yenerçağ; Ahmet Kaya; Yusuf Ziya Şener; Ali Bağcı
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-12       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.